Dr Steven Burakoff | Director, Tisch Cancer Institute, Professor Oncological Sciences, Professor Medicine, Hematology and Medical Oncology
Tisch Cancer Institute Mount Sinai

Dr Steven Burakoff, Director, Tisch Cancer Institute, Professor Oncological Sciences, Professor Medicine, Hematology and Medical Oncology, Tisch Cancer Institute Mount Sinai

Steven J. Burakoff, M.D., is currently the Lillian and Henry Stratton Professor of Medicine and the Director of The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, Mount Sinai Health System (MSHS).  Dr. Burakoff, prior to his appointment in 2007 to the Icahn School of Medicine at Mount Sinai, was the Laura and Isaac Perlmutter Professor at New York University School of Medicine, the Director of the New York University Cancer Institute, and the Director of the Skirball Institute of Biomolecular Medicine.  Prior to joining the New York University School of Medicine, in 2000, he was Chair of Pediatric Oncology at the Dana-Farber Cancer Institute and the Margaret M. Dyson Professor of Pediatrics at the Harvard Medical School, and also received an Honorary Master’s of Science Degree from Harvard University. He was the recipient of the first Harvard Medical School Excellence in Mentoring Award.  He was also the Ted Williams Senior Investigator at the Dana-Farber Cancer Institute, and served as a member of the Board of Trustees of the Dana-Farber Cancer Institute.  Dr. Burakoff serves as a member of the External Advisory Committee of the Cold Spring Harbor Laboratory Cancer Center. He is also on the Board of Directors of the Damon Runyon Cancer Foundation and he is on the Joint Scientific Advisory Board for Stand Up to Cancer. Dr. Burakoff holds memberships in many professional societies and organizations, including: Alpha Omega Alpha, the American Society of Clinical Investigation, and the Association of American Physicians, and the American Association of Immunologist where he served as Secretary-Treasurer. 
He has been an Editor and Associate Editor for numerous journals and author of more than 300 publications in peer-reviewed journals.  In 2009, Dr. Burakoff received the American Association of Immunologists Lifetime Achievement Award.

Appearances:



Agenda Day 2 @ 08:40

Precision oncology needs data sharing: Integrating genomic and clinical data to advance patient care and understanding patient outcomes

  • Does decoding the genes of patients’ cancer help to accelerate the pace of discovery?
  • Is more sequencing, across large populations worthwhile?
  • How to combine all these data into one searchable pool?
  • How will this translate to better and more personalized vaccines or treatments for patients?
  • The paradigm of bringing multiple cancer centers together, connecting academics with industry and how to data share
  • The type of data sharing necessary to learn from the experience of patients that go through cancer immunotherapy

back to speakers